Congress Just Saved Federal Research Funding. Here Is Exactly What Survived, What Didn't, and What It Means for Your Next Proposal.

After the longest government shutdown in U.S. history and a presidential budget request that proposed gutting the National Institutes of Health by 40 percent, Congress did something remarkable: it funded science anyway. The FY2026 appropriations package, passed by the House in January and now working through the Senate, delivers $48.7 billion to NIH — a $415 million increase over the prior year — and preserves nearly every major federal research and education program that the White House had targeted for elimination.

For the roughly 300,000 researchers, 50,000 nonprofits, and thousands of small businesses that depend on federal grant funding, the numbers in this bill are not just budget lines. They are the difference between labs that stay open and labs that close, between programs that hire and programs that cut, between proposals worth writing and funding streams that no longer exist.

The NIH Numbers

The headline figure — $48.7 billion in discretionary funding for NIH — represents a "near-total rebuke" of the administration's proposed restructuring, according to STAT News. The administration had sought to reduce NIH to roughly $29 billion, consolidate institutes, and cap indirect cost reimbursement at 15 percent. Congress rejected all three.

The indirect cost rate fight was the most consequential for research institutions. Indirect costs — the overhead that universities charge on federal grants to cover facilities, administration, and infrastructure — typically range from 50 to 70 percent of direct costs at major research universities. The administration's proposed 15 percent cap would have stripped billions from institutional budgets, forcing universities to either absorb the loss or reduce the number of grants they could support. The final bill explicitly blocks the NIH indirect cost cap, preserving negotiated rates.

Specific institute allocations reflect bipartisan priorities. The National Cancer Institute receives $7.4 billion, including $28 million for the Childhood Cancer STAR Act. NIAID — the infectious disease institute that became a political lightning rod during the pandemic — receives $6.6 billion, a $23 million increase that signals congressional intent to maintain infectious disease research capacity regardless of White House preferences.

What the administration did win: continuation of the "forward funding" strategy implemented in 2025, which front-loads multi-year grant commitments into current-year budgets. This accounting maneuver means NIH can report higher per-grant funding while actually making fewer awards. The practical effect, as researchers have discovered over the past year, is that several thousand fewer new grants will be issued even though the total budget increased. (Granted News)

Education Funding Holds

The Department of Education emerges with $79 billion in discretionary funding — $217 million above FY2025 and approximately $12 billion above the administration's request. Congress rejected proposals to eliminate or significantly reduce programs that serve low-income and underrepresented students.

Pell Grants maintain their maximum award at $7,395 for the 2026-2027 academic year, defeating a proposed cut exceeding $1,000 per student. For the 6.5 million students who rely on Pell Grants, that preserved $1,000 per recipient is the margin between enrollment and dropout.

TRIO and GEAR UP — the pipeline programs that prepare first-generation college students for higher education — survived elimination proposals. These programs serve over 800,000 students annually, and their preservation means that the institutional partnerships built over decades between universities and community organizations remain funded.

Minority-Serving Institutions received increased Title III and Title V funding despite Justice Department challenges to race-conscious programs. This is notable because the increased allocation directly contradicts the administration's legal posture on race-conscious federal spending.

The Institute of Education Sciences received $790 million, tripling the administration's request of $261 million. IES funds the research infrastructure that underpins evidence-based education policy — the randomized controlled trials, longitudinal studies, and data systems that tell policymakers what actually works. The gap between the request and the appropriation reveals how far apart Congress and the White House are on whether education research is worth funding.

NSF Takes a Cut — But Survives

The National Science Foundation receives $8.75 billion, a 3.4 percent reduction from FY2024 but dramatically better than the 57 percent cut the president proposed. The Research and Related Activities account — NSF's core funding for investigator-initiated research — receives $7.2 billion. STEM Education receives $938 million, a 20 percent decrease from prior years but a tripling of the administration's $288 million request.

For NSF-funded researchers, the practical message is: funding rates will tighten but not collapse. NSF has historically funded 25 to 28 percent of proposals in its core programs. At $7.2 billion for R&RA — roughly flat to recent years — funding rates should hold in the low-to-mid twenties. The STEM Education cut is more painful, particularly for institutions that built programs around NSF's expanded education funding during the CHIPS and Science Act era.

What Grant Seekers Should Do Now

The spending bill's passage does not mean business as usual. The combination of preserved budgets, the forward-funding accounting shift, and the ongoing regulatory changes create a landscape that rewards strategic adaptation.

NIH applicants should understand that a $415 million increase in the total NIH budget does not mean more grants. The forward-funding mechanism reduces the number of new awards even as the total budget grows. Principal investigators should expect R01 funding rates in the 18 to 22 percent range — competitive but not catastrophic. The more immediate concern is the ongoing disruption documented in a STAT News survey of NIH-funded researchers, which found that more than a quarter of respondents have laid off lab members and more than two in five have canceled planned research projects.

The researchers most likely to secure funding are those who align proposals with congressional priorities visible in the bill's language: cancer (the STAR Act allocation signals continued emphasis), infectious disease preparedness, Alzheimer's research, and precision medicine. Proposals that can demonstrate relevance to multiple institutes — and that leverage the cross-cutting themes Congress is explicitly funding — will have an edge in an environment where study sections are making fewer awards.

Education grant seekers should recognize that Congress is protecting these programs against executive branch opposition. That dynamic creates both opportunity and risk. The opportunity is that funding levels remain high and program officers are motivated to make awards that demonstrate program value. The risk is that award conditions may tighten as agencies add oversight requirements to satisfy an administration that opposed the funding.

The new Workforce Pell Grant program — enabling students to use federal grant funds for short-term programs as brief as eight weeks, starting July 2026 — opens a genuinely new category of institutional partnerships. Community colleges, workforce boards, and training providers that can demonstrate rapid employment outcomes for Pell-eligible students should start building compliant programs now.

NSF applicants face the most nuanced calculus. Core research funding is roughly flat, which means the competition for R&RA dollars is fierce but stable. The STEM Education cut, however, creates a gap that state governments and philanthropic funders may step in to fill. Researchers whose work spans the research-education boundary should explore NSF's Broader Impacts framework aggressively — reviewers will reward proposals that serve education goals within research budgets.

The Senate Obstacle

The House-passed bill still requires Senate action and presidential signature. Senate Democrats have signaled potential opposition tied to Department of Homeland Security funding within the broader package, and the administration could veto a bill that blocks its indirect cost cap and funds programs it sought to eliminate.

If the bill stalls, agencies will operate under continuing resolution authority at FY2025 levels — functionally flat funding without the $415 million NIH increase or the education program expansions. A prolonged CR would delay new grant announcements, extend review timelines, and create the kind of uncertainty that discourages early-career researchers from submitting proposals at all.

The most likely outcome is eventual passage with minor modifications. Bipartisan support for NIH and education funding is strong enough in both chambers to override the administration's objections, but the timeline is uncertain. Grant seekers should prepare proposals assuming the bill passes as written while maintaining contingency plans for a CR scenario.

The Larger Pattern

Zoom out from the specific numbers and a pattern emerges. Federal research funding has survived every attempt to cut it dramatically — the 2013 sequestration, the 2017 and 2018 proposed eliminations, the 2025 restructuring, and now the 2026 budget request. Each time, bipartisan coalitions in Congress preserve the essential architecture of federal science funding, sometimes over the explicit objections of the White House.

This pattern is not a guarantee. Each cycle strains institutional capacity as agencies manage hiring freezes, delayed awards, and the uncertainty that drives talented researchers toward private-sector careers. The STAT News survey found that two-thirds of NIH-funded researchers are counseling students to consider careers outside academia — a brain drain that no budget increase can quickly reverse.

But for grant seekers working within the system as it exists today, the FY2026 bill sends a clear signal: federal research and education funding is not going away, and the organizations that continue to submit competitive proposals through the turbulence will be the ones that benefit when certainty returns. Granted can help you navigate the specific solicitations, align your proposals with congressional priorities, and build applications that stand out in a competitive but well-funded landscape.